Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients-Reference-Cited by-同舟云学术

Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients

Published:2017-12-20 Issue:3 Volume:57 Page:332-338
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Vinay Keshavamurthy¹^ORCID,Yanamandra Uday²,Dogra Sunil¹,Handa Sanjeev¹,Suri Vikas²,Kumari Savita²,Khadwal Alka²,Prakash Gaurav²,Lad Deepesh²,Varma Subhash²,Malhotra Pankaj²

Affiliation:

1. Department of Dermatology, Venereology and Leprology; Postgraduate Institute of Medical Education and Research; Chandigarh India

2. Department of Hematology; Postgraduate Institute of Medical Education and Research; Chandigarh India

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijd.13852/fullpdf

Reference23 articles.

1. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

2. First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response - systematic review and meta-analysis;Gurion;Acta Oncol (Madr),2016

3. Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment;Kekale;Patient Prefer Adherence,2015

4. Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis;Breccia;Support Care Cancer,2016

5. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients;Valeyrie;J Am Acad Dermatol,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leukotrichia due to generic dasatinib;Journal of Hematology and Allied Sciences;2023-12-30

2. Bioactive Pentacyclic Triterpenes Trigger Multiple Signalling Pathways for Selective Apoptosis Leading to Anticancer Efficacy: Recent Updates and Future Perspectives;Current Protein & Peptide Science;2023-12

3. Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?;Clinics and Practice;2023-09-05

4. Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience;Pharmacology Research & Perspectives;2022-09-14

5. Paradoxical Pandora's box of pigmentary side effects by imatinib mesylate in case of chronic myeloid leukemia;Dermatologic Therapy;2022-03